SEC Form 4 · accession 0000899243-15-010242
ZS Pharma, Inc. · ZSPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Guy P Nohra
Director
Period of report
Dec 17, 2015
Accepted (ET)
Dec 21, 2015 · 8:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001459266
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 17, 2015 | D | 1,000 | $90.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (NQ) - 8/22/14 | $32.56 | Dec 17, 2015 | D | 12,000 | D | Aug 22, 2015 | Aug 21, 2024 | Common Stock | 12,000 | 0 | D |
| Stock Options (NQ) - BOD 6/18/15 | $55.57 | Dec 17, 2015 | D | 4,000 | D | Jun 18, 2016 | Jun 17, 2025 | Common Stock | 4,000 | 0 | D |
Explanation of responses
- F1Includes 1,000 shares in the form of restricted stock units